It is a low float 16.6 Million share stock, if they raise any cash. pps will go down quiet a bit. Any new corporate investor wil look for a deal..... How much. will this be more than $15....?
With FDA approval funding is a non issue.
Sentiment: Strong Buy
No they dont have enough cash as they only raised about half of what they were looking for on the IPO so a secondary is clearly in the offing. In biotech you raise when you can or have good news.
"they only raised about half of what they were looking for on the IPO"
Incorrect. Target IPO pps was $11-13, they IPO'd at $10.
or there is speculation they are selling the company and thats whats driving the stock